CVS Health Price Target Raised to $66.00/Share From $60.00 by Wells Fargo
CVS Health's 2025 'Less Certain' Following 2024 Guidance Withdrawal, Changes in Leadership, RBC Capital Says
CVS Health Raised to Overweight From Equal-Weight by Wells Fargo
Today's Analyst Rating | NVIDIA Price Target Raised to $189 by Evercore, Taiwan Semiconductor Price Target Raised to $240 by Barclays
CVS Health Shares Are Trading Higher After the Company Announced the Addition of Four New Directors to Its Board.
CVS Adds 4 New Board Members After Activist Push -- Barrons.com
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
